No significant differences were observed in cNOS levels (Figure 4F) with early SS treatment (LPS + SS 0.355 ± 0.04 vs. LPS + Saline 0.38 ± 0.032 pmol Arg/μg protein; control 0.31 ± 0.028 vs. LPS + SS 0.355 ± 0.04 pmol Arg/μg protein) or late SS treatment (LPS + SS 0.328 ± 0.04 vs. LPS + Saline 0.454 ± 0.032 pmol Arg/μg protein; control 0.329 ± 0.02 vs. LPS + SS 0.328 ± 0.04 pmol Arg/μg protein). Here, NOS3 is linked to synovial sarcoma.